About this episode
欢迎收听今日医学播客焦点！最新研究显示，一种名为tegopru的抗体药物在治疗肌萎缩性脊髓侧索硬化症（ALS）方面取得突破性进展。这项2A期临床试验涉及54名患者，结果显示tegopru不仅安全耐受，还能降低与ALS相关的18种促炎生物标志物。这一发现为ALS患者带来新的治疗希望，值得进一步研究以评估其临床效果。不要错过，让我们一起关注ALS治疗的新进展！
Get every episode summarized
Each time 萌喵读文献-神经病学 publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
